Heart drug study pulled before it even started
NCT ID NCT04510792
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was designed to find out how often high potassium levels (hyperkalemia) cause doctors to reduce or stop important heart medications called RAAS inhibitors in emergency room or hospitalized patients. It planned to track medication changes and repeated high potassium episodes. However, the study was withdrawn before enrolling any participants, so no data or results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERKALEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital
Portsmouth, Hampshire, PO6 3LY, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which works best for high potassium? new study tests three emergency options
- Could less insulin be better for high potassium? new trial aims to find out
- Potassium binder lets heart patients get full drug benefits
- New study aims to find safer heart failure treatment for kidney patients
- Could kidney patients eat more fruits and veggies safely?
- Smart patch could spot silent killer in kidney patients without needles